SEARCH

SEARCH BY CITATION

References

  • Alberts, D.S., Chen, H.G., Benz, D. & Mason, N.L. (1981) Effect of renal dysfunction in dogs on the disposition and marrow toxicity of melphalan. British Journal of Cancer, 43, 330334.
  • Badros, A., Barlogie, B., Siegel, E., Roberts, J., Langmaid, C., Zangari, M., Disikan, R., Shaver, M.J., Fassas, A., McConnell, S., Muwalla, F., Barri, Y., Anaissie, E., Munshi, N. & Tricot, G. (2001) Results of autologous stem cell transplantation in multiple myeloma patients with renal failure. British Journal of Haematology, 114, 822829.
  • Cockcroft, D.W. & Gault, M.H. (1976) Prediction of creatinine clearance from serum creatinine. Nephron, 16, 3141.
  • Cornwell, G.G. III, Pajak, T.F., McIntyre, O.R., Kochwa, S. & Dosik, H. (1982) Influence of renal failure on myelosuppressive effect of melphalan: cancer and Leukemia Group B experience. Cancer Treatment Report, 66, 475481.
  • Durie, B.G., Kyle, R.A., Belch, A., Bensinger, W., Blade, J., Boccadoro, M., Child, J.A., Comenzo, R., Djulbegovic, B., Fantl, D., Gahrton, G., Harousseau, J.L., Hungria, V., Joshua, D., Ludwig, H., Mehta, J., Morales, A.R., Morgan, G., Nouel, A., Oken, M., Powles, R., Roodman, D., San Miguel, J., Shimizu, K., Singhal, S., Sirohi, B., Sonneveld, P., Tricot, G., Van Ness, B. & Scientific Advisors of the International Myeloma Foundation (2003) Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. The Hematology Journal, 4, 379398.
  • Knudsen, L., Hippe, E., Hjorth, M., Holmberg, E., Westin, J., for the Nordic Myeloma Study Group (1994). Renal function in newly diagnosed multiple myeloma – a demographic study of 1353 patients. European Journal of Haematology, 53, 207212.
  • Österborg, A, Ehrsson, H, Eksborg, S, Wallin, I & Mellstedt, H. (1989) Pharmacokinetics of oral melphalan in relation to renal function in multiple myeloma patients. European Journal of Cancer and Clinical Oncology 25, 899903..
  • The Nordic Myeloma Study Group (1996) Interferon-α2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. Annals of Internal Medicine, 124, 212222.
  • The Nordic Myeloma Study Group (2001) Nordiskt vårdprogram; Myelomatose, diagnostik og behandling, 30. Available at: http://216.239.59.104/search?q=cache:l6tWcxc5h30J:www.svls.se/sektioner/he/filarkiv/files/vardprogram_myelom.doc+Nordiskt+vrdprogram%3B+Myelomatose,+diagnostik+og+behandling,+30&hl=en
  • The UK Myeloma Forum (2001). Guidelines. Diagnosis and management of multiple myeloma. British Journal of Haematology, 115, 522540.